JONI MCINTYRE: Open Payments
NPI 1881875128 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$948 in 32 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $1,671 · 2025 $948
Food & beverage: $948
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 14 | $366 |
| Gilead Sciences, Inc. | 2 | $185 |
| ABBVIE INC. | 5 | $111 |
| AstraZeneca Pharmaceuticals LP | 3 | $105 |
| Ipsen Biopharmaceuticals, Inc | 4 | $101 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $62 |
| ORPHALAN INC | 1 | $17 |
Products named: REZDIFFRA, Vemlidy, MAVYRET, IQIRVO, XIFAXAN, BEVESPI AEROSPHERE, CUVRIOR.
Industry payments across AZ — which companies pay providers there.
